Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
- Status
- TERMINATED
- Phase
- N/A
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Radiotherapy for NSCLC to a Individualized MLD
- Status
- COMPLETED
- Phase
- N/A
Concurrent Chemo-radiation Form NSCLC to a Individualized MLD
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
- Status
- COMPLETED
- Phase
- PHASE2
TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2